Sacubitril/Valsartan Sodium Tablets 100mg (Yixintan) – Factory low price wholesale

Sacubitril/Valsartan Sodium Tablets 100mg (Yixintan) – Factory low price wholesale

$1.00

Yixintan brand Sacubitril/Valsartan Tablets provide 100mg per tablet, packaged as 7 tablets × 2 blisters per box. Approved by China NMPA (H20234043), manufactured by Jiangsu Xuantai Pharmaceutical Co., Ltd. For laboratory research use only. Available for wholesale and retail.?Please consult staff for price, other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare
Category:

Description

Sacubitril/Valsartan Sodium Tablets (Yixintan) are a dual-acting cardiovascular research compound combining a neprilysin inhibitor (sacubitril) with an angiotensin II receptor blocker (valsartan). The combination is widely researched for its effects in heart failure, cardiac remodeling, and neurohormonal regulation.

Each tablet contains 100mg of the active compound (sacubitril/valsartan), with 14 tablets per box (7 tablets × 2 blisters). The product is manufactured by Jiangsu Xuantai Pharmaceutical Co., Ltd., approved under Chinese NMPA license H20234043, and identified by the national product code 86981522000122.

?? For laboratory research only. Not for human or veterinary use.


Sacubitril/Valsartan Sodium Product Specifications

ParameterDetails
Product NameSacubitril/Valsartan Sodium Tablets (Yixintan)
Generic NameSacubitril and Valsartan Sodium
CAS Number936623-90-4 (Sacubitril), 137862-53-4 (Valsartan)
Molecular FormulaC24H29NO5 (Sacubitril), C24H29N5O3 (Valsartan)
Molecular Weight~411.5 g/mol (Sacubitril), ~435.5 g/mol (Valsartan)
Dosage FormTablet
Strength100mg per tablet
Quantity14 tablets per box (2 blisters × 7 tablets)
Approval NumberH20234043
Product Code86981522000122
ManufacturerJiangsu Xuantai Pharmaceutical Co., Ltd.
Storage ConditionsStore below 25°C; avoid moisture and light
Intended UseFor laboratory research only
Barcode6973355390055

Sacubitril/Valsartan Sodium Mechanism & Research Applications

Sacubitril/Valsartan exhibits dual pharmacological action: sacubitril inhibits neprilysin, increasing beneficial peptides like natriuretic peptides, while valsartan blocks angiotensin II receptors, reducing vasoconstriction and aldosterone release. This synergistic effect reduces blood pressure and improves cardiac remodeling.

Research applications include:

  • Laboratory models of chronic heart failure (HFrEF)

  • Neprilysin inhibition pharmacology

  • RAAS modulation and vascular function assays

  • Studies in ventricular remodeling and myocardial fibrosis

  • Comparative studies with ACE inhibitors and ARBs


Safety & Handling

  • Use Restriction: For laboratory research only. Not for therapeutic, diagnostic, or veterinary use.

  • Handling Requirements: Use PPE—gloves, safety goggles, and lab coat.

  • Storage: Store in a sealed container below 25°C; keep dry and protected from light.

  • Disposal: Dispose of according to institutional lab chemical waste procedures.


Research Use Disclaimer

This product is intended exclusively for laboratory research use and is not certified for therapeutic, diagnostic, or veterinary applications. Improper use may pose legal and safety risks. Always follow local biosafety and research compliance protocols.

Additional information

Weight1 kg
Dimensions28 × 26 × 28 cm

Reviews

There are no reviews yet.

Be the first to review “Sacubitril/Valsartan Sodium Tablets 100mg (Yixintan) – Factory low price wholesale”

Your email address will not be published. Required fields are marked *

Q1: Can this product be used in clinical or veterinary settings?

A1: No, this is strictly for experimental and laboratory research only.

Q2: Are wholesale and retail purchases available?

A2: Yes, both options are supported. Contact us for bulk pricing tiers.

Q3: Is documentation such as COA or SDS available?

A3: Yes. Certificate of Analysis (COA) and Safety Data Sheet (SDS) are available upon request.

Q4: What are common experimental applications?

A4: Common uses include heart failure model testing, RAAS interaction studies, and vascular function analysis.

Q5: How is the product packaged?

A5: Each box includes 14 tablets, split into two blisters of 7 tablets.


EMI Options

Select at least 2 products
to compare